Teva Pharmaceutical Industries shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Teva Pharmaceutical Industries by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $18M | 1.0M | 18.05 |
| 2024-06-30 | $8.6M | 529k | 16.27 |
| 2024-03-31 | $5.8M | 411k | 14.10 |
| 2023-12-31 | $3.4M | 322k | 10.44 |
| 2023-09-30 | $3.2M | 324k | 9.97 |
| 2023-06-30 | $2.5M | 330k | 7.53 |
| 2022-12-31 | $2.2M | 257k | 8.49 |
| 2022-09-30 | $7.7M | 869k | 8.85 |
| 2021-06-30 | $7.3M | 736k | 9.91 |
| 2021-03-31 | $8.3M | 723k | 11.54 |
| 2020-12-31 | $14M | 1.5M | 9.65 |
| 2020-09-30 | $4.1M | 452k | 9.06 |
| 2020-06-30 | $6.1M | 493k | 12.33 |
| 2020-03-31 | $4.5M | 517k | 8.62 |
| 2019-12-31 | $13M | 1.3M | 9.80 |
| 2019-09-30 | $18M | 2.6M | 6.85 |
| 2019-03-31 | $23M | 1.5M | 15.67 |
| 2018-12-31 | $30M | 2.0M | 15.12 |
| 2018-09-30 | $33M | 1.5M | 21.55 |
| 2018-06-30 | $38M | 1.5M | 24.72 |
| 2018-03-31 | $28M | 1.6M | 17.08 |
| 2017-12-31 | $67M | 3.5M | 18.95 |
| 2016-12-31 | $162M | 4.5M | 36.25 |
| 2016-09-30 | $137M | 3.0M | 46.01 |
| 2016-06-30 | $147M | 2.9M | 50.23 |
| 2016-03-31 | $157M | 2.9M | 53.48 |
| 2015-12-31 | $176M | 2.7M | 65.65 |
| 2015-09-30 | $134M | 2.4M | 56.46 |
| 2015-03-31 | $113M | 1.8M | 62.28 |
| 2014-12-31 | $110M | 1.9M | 57.51 |
| 2014-09-30 | $87M | 1.6M | 53.75 |
| 2014-06-30 | $71M | 1.4M | 52.42 |
| 2014-03-31 | $83M | 1.6M | 52.84 |
| 2013-12-31 | $69M | 1.7M | 40.09 |
| 2013-09-30 | $101M | 2.7M | 37.77 |
| 2011-09-30 | $74M | 2.0M | 37.23 |
| 2011-06-30 | $85M | 1.8M | 48.21 |
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries